Kiniksa Pharmaceuticals, Ltd. (KNSA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:18AM EDT. Market open.
| Previous close | 20.19 |
| Open | 20.05 |
| Bid | 20.08 x 200 |
| Ask | 20.20 x 100 |
| Day's range | 20.05 - 20.50 |
| 52-week range | 13.02 - 22.09 |
| Volume | |
| Avg. volume | 394,356 |
| Market cap | 1.429B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 155.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After Its First-Quarter Report
It's been a good week for Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) shareholders, because the company has just...
- Simply Wall St.
Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) First Quarter 2024 Results Key Financial Results Revenue: US$79.9m (up 65% from...
- Insider Monkey
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
© 2024 Yahoo. All rights reserved.